Drug intelligence / Profile preview

MegaRed

Development stage
Unknown
Lead developer
Schiff Vitamins
Modality
Small Molecules
Administration
Oral
01

Overview

MegaRed is a brand of over-the-counter dietary supplements primarily composed of omega-3 fatty acids derived from krill oil and fish oil. Marketed by Schiff (a subsidiary of Reckitt Benckiser), the product line includes various formulations such as MegaRed Omega-3 Krill Oil and MegaRed Advanced 4-in-1. The active ingredients, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are often delivered in phospholipid form when sourced from krill, which is marketed as providing superior absorption compared to traditional fish oil. MegaRed is used to support cardiovascular health by helping to maintain healthy triglyceride levels and is also promoted for joint, brain, and eye health. As a dietary supplement, it is not regulated as a pharmaceutical drug and is not intended to diagnose, treat, cure, or prevent any disease.

Brand names
MegaRedMegaRed Omega-3 Krill OilMegaRed Advanced 6X AbsorptionMegaRed Advanced 4-in-1
Other names
Krill oilOmega-3 krill oilOmega3 krill oilOmega 3 krill oil
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on MegaRed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MegaRed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call